Correlation between Skip N2 Metastases and SUV_max, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer

Table 1

General characteristics of the 65 NSCLC patients.

Variables	(%)
Age
<60 yrs	16 (24.6%)
≥60 yrs	49 (75.4%)
Pathological type
Adenocarcinoma	36 (55.4%)
Squamous carcinoma	26 (40.0%)
Adenosquamous carcinoma	2 (3.1%)
Lymphoma-like carcinoma	1 (1.5%)
T staging
T1	22 (33.8%)
T2	28 (40.3%)
T3	12 (19.4%)
T4	3 (6.5%)
N staging
N1a	14 (21.5%)
N1b	4 (6.2%)
N2a1	19 (29.2%)
N2a2	15 (23.1%)
N2b	13 (20.0%)
TNM staging
IIB	22 (33.8%)
IIIA	34 (52.3%)
IIIB	9 (13.8%)

NSCLC: non-small-cell lung cancer.